Pure Cycle Corp: Form 10-Q for the period ended Feb 29, 2024
Filed with the SEC on Apr 10, 2024 and accepted by EDGAR at Apr 10, 2024, 16:01 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2024-02-29. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2023-12-01 to 2024-02-29 | $3.2m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Revenue | 6 months2023-09-01 to 2024-02-29 | $8.6m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 3 months2023-12-01 to 2024-02-29 | $1.4m | us-gaap:CostOfRevenue |
| Cost of revenue | 6 months2023-09-01 to 2024-02-29 | $3.5m | us-gaap:CostOfRevenue |
| Gross profit | 3 months2023-12-01 to 2024-02-29 | $1.8m | us-gaap:GrossProfit |
| Gross profit | 6 months2023-09-01 to 2024-02-29 | $5.1m | us-gaap:GrossProfit |
| Operating income | 3 months2023-12-01 to 2024-02-29 | −$368.0k | us-gaap:OperatingIncomeLoss |
| Operating income | 6 months2023-09-01 to 2024-02-29 | $1.4m | us-gaap:OperatingIncomeLoss |
| Income tax | 3 months2023-12-01 to 2024-02-29 | $41.0k | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 6 months2023-09-01 to 2024-02-29 | $778.0k | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2023-12-01 to 2024-02-29 | $118.0k | us-gaap:NetIncomeLoss |
| Net income | 6 months2023-09-01 to 2024-02-29 | $2.2m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2023-12-01 to 2024-02-29 | $0.00 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 6 months2023-09-01 to 2024-02-29 | $0.09 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2023-12-01 to 2024-02-29 | $0.00 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 6 months2023-09-01 to 2024-02-29 | $0.09 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2023-12-01 to 2024-02-29 | 24,149,195 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 6 months2023-09-01 to 2024-02-29 | 24,149,524 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 6 months2023-09-01 to 2024-02-29 | −$1.7m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Share repurchases | 6 months2023-09-01 to 2024-02-29 | $298.0k | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2024-02-29 | $20.4m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2024-02-29 | $26.4m | us-gaap:AssetsCurrent |
| Total assets | At period end2024-02-29 | $135.2m | us-gaap:Assets |
| Current liabilities | At period end2024-02-29 | $6.4m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2024-02-29 | $14.8m | us-gaap:Liabilities |
| Long-term debt | At period end2024-02-29 | $6.9m | us-gaap:LongTermDebtNoncurrent |
| Current portion of debt | At period end2024-02-29 | $33.0k | us-gaap:LongTermDebtCurrent |
| Shareholders' equity | At period end2024-02-29 | $120.4m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001558370-24-004922. Last ingested by Listed: Oct 24, 2026, 14:55 ET. Listed shows no prices and gives no investment advice.